Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras

Journal of Clinical Investigation

Volumn 99, Issue 12, 1997, Pages 2842-2850

  Brack, Alexander ^a   Rittner, Heike L ^a   Younge, Brian R ^a   Kaltschmidt, Christian ^b   Weyand, Cornelia M ^a   Goronzy, Jörg J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Giant cell arteritis; NF B; SCID mouse; TGF ; Vasculitis

Indexed keywords

CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; DOSE RESPONSE; GENE REPRESSION; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; STEROID THERAPY; TEMPORAL ARTERY; XENOTRANSPLANTATION;

EID: 0030961240     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119477     Document Type: Article

References (32)

1. Huston, K.A., G.G. Hunder, J.T. Lie, R.H. Kennedy, and L.R. Elveback. 1978. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann. Intern. Med. 88:162-167.
2. Weyand, C.M., J. Schönberger, U. Oppitz, N.N.H. Hunder, K.C. Hicok, and J.J. Goronzy. 1994. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J. Exp. Med. 179:951-960.
3. Weyand, C.M., K.C. Hicok, G.G. Hunder, and J.J. Goronzy. 1994. Tissue cytokine patterns in polymyalgia rheumatica and giant cell arteritis. Ann. Intern. Med. 121:484-491.
4. Weyand, C.M., A.D. Wagner, J. Björnsson, and J.J. Goronzy. 1996. Correlation of topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J. Clin. Invest. 98:1642-1649.
5. Wagner, A.D., J. Björnsson, G.B. Bartley, J.J. Goronzy, and C.M. Weyand. 1996. Interferon gamma producing T cells in giant cell vasculitis represent a minority of tissue infiltrating cells and are located distant from the site of pathology. Am. J. Pathol. 148:1925-1933.
6. Yang-Yen, H.F., J.C. Chambard, Y.L. Sun, T. Smeal, T.J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 62:1205-1215.
7. Schule, R., P. Rangarajan, S. Kliewer, L.J. Ransone, J. Bolado, N. Yang, I.M. Verma, and R.M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 62:1217-1226.
8. Jonat, C., H.J. Rahmsdorf, K.K. Park, A.C. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62:1189-1204.
9. Paliogianni, F., A. Raptis, S.S. Ahuja, S.M. Najjar, and D.T. Boumpas. 1993. Negative transcription regulation of the human interleukin-2 gene by glucocorticoids through interference with nuclear factors AP-1 and NF-AT. J. Clin. Invest. 91:1481-1489.
10. Scheinman, R.I., P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression of glucocorticoids. Science (Wash. DC). 270:283-286.
11. Auphan, N., J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science (Wash. DC). 270:286-290.
12. Brack, A., V. Martinez-Taboada, J. Björnsson, B.R. Younge, C.M. Weyand, and J.J. Goronzy. 1995. Persistence of giant cell vasculitis in xenotransplants indicates the presence of a disease relevant antigen residing in the arterial wall. Arthritis Rheum. 38:S404(Abstr.).
13. Kaltschmidt, C., B. Kaltschmidt, T. Henkel, H. Stockinger, and P.A. Baeuerle. 1995. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol. Chem. Hoppe-Seyler. 376:9-16.
14. Schreck, R., B. Meier, D.N. Männel, W. Dröge, and P.A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181-1194.
15. Boumpas, D., G.P. Chrousos, R.L. Wilder, T.R. Cupps, and J.E. Balow. 1993. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 119:1198-1208.
16. Baldwin, A.S. 1996. The NFκB and IκB proteins - New discoveries and insights. Annu. Rev. Immunol. 14:649-683.
17. Roche, N.E., J.W. Fulbright, A.D. Wagner, G.G. Hunder, J.J. Goronzy, and C.M. Weyand. 1993. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 36: 1286-1294.
18. Yoshizaki, K., T. Kuritani, and T. Kishimoto. 1992. Interleukin-6 in autoimmune disorders. Semin. Immunol. 4:155-166.
19. + cells in giant cell arteritis. Evidence for two components of the disease. J. Clin. Invest. 94:1134-1140.
20. Weyand, C.M., N. Tetzlaff, J. Björnsson, and J.J. Goronzy. 1997. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 40:19-26.
21. AyanlarBatuman, O., A.P. Ferrero, A. Diaz, and S.A. Jimenez. 1991. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J. Clin. Invest. 88:1574-1580.
22. Batuman, O.A., A. Ferrero, C. Cupp, S.A. Jimenez, and K. Khalili. 1995. Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. J. Immunol. 155:4397-4405.
23. Wahl, S.M. 1994. Transforming growth factor beta: the good, the bad, and the ugly. J. Exp. Med. 180:1587-1590.
24. Lowrance, J.H., F.X. O'Sullivan, T.E. Caver, W. Waegell, and H.D. Gresham. 1994. Spontaneous elaboration of transforming growth factor β suppresses host defense against bacterial infection in autoimmune MRL/1pr mice. J. Exp. Med. 180:1693-1703.
25. Barral-Netto, M., A. Barral, C.E. Brownell, Y.A. Skeiky, L.R. Ellingsworth, D.R. Twardzik, and S.G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science (Wash. DC). 257: 545-548.
26. Alien, J.B., C.L. Manthey, A.R. Hand, K. Ohura, L. Ellingsworth, and S.M. Wahl. 1990. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β. J. Exp. Med. 171:231-247.
27. Wahl, S.M., J.B. Allen, G.L. Costa, H.L. Wong, and J.R. Dasch. 1993. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor β J. Exp. Med. 177:225-230.
28. Wahl, S.M., D.A. Hunt, L.M. Wakefield, N. McCartney-Francis, L.M. Wahl, A.B. Roberts, and M.B. Sporn. 1987. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA. 84:5788-5792.
29. Wahl, S.M., J.B. Allen, B.S. Weeks, H.L. Wong, and P.E. Klotman. 1993. TGF-β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA. 90:4577-4581.
30. McCartney-Francis, N., J.B. Alien, D.E. Mizel, J.E. Albina, Q.W. Xie, C.F. Nathan, and S.M. Wahl. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:749-754.
31. Clancy, R.M., and S.B. Abramson. 1995. Nitric oxide. A novel mediator of inflammation. Proc. Soc. Exp. Biol. Med. 210:93-101.
32. Luscher, T.F., R.R. Wenzel, and G. Noll. 1995. Local regulation of the coronary circulation in health and disease: role of nitric oxide and endothelin. Eur. Heart. J. 16(Suppl. C):51-58.